Search

everythinglearnresearchcommunity

for

Search:↓

CD28 is a promising target for treating alopecia areata with belatacept.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

TLR3 activation helps improve skin and hair follicle healing in mice.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Tislelizumab can cause cutaneous lupus erythematosus.

Dandruff is linked to increased T cells and weakened immune protection in hair follicles.

Activating TLR3 boosts autophagy gene expression in skin cells.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

Increasing PDCD4 protein may help prevent or treat some skin cancers.

TCDD changes skin cell growth and keratin production in mice.

The document doesn't provide a clear conclusion or detailed findings about the impact of certain cells on cancer treatment.

Immune cells called Treg cells are essential for hair growth and regeneration.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

A specific type of immune cells, called CD301b-expressing macrophages, are crucial for skin repair processes.

Regulatory T cells help heal skin wounds by reducing inflammation and promoting tissue repair.

Tumor proteins can both promote and suppress cancer, depending on the situation.

A specific group of immune and skin cells may cause chronic inflammation in atopic dermatitis.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

BST2 protein and certain T cells increase in early alopecia areata.

Highly active but fewer CD14+CD16- monocytes are found in Alopecia Areata patients, regardless of severity.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

Removing certain immune cells in mice causes their hair to enter the growth phase earlier than usual.

Stat3 influences keratinocyte stem cell behavior, affecting differentiation and migration.

Alopecia areata involves specific immune cells, offering potential treatment targets.

Deleting the MAD2L1 gene in mice led to rapid tumor growth despite chromosomal instability.

Increasing regulatory T cells may help treat alopecia areata by reducing autoimmunity and promoting hair growth.

Stem cell activity influences autoimmune disease outcomes by affecting immune responses and tissue regeneration.

Inflammation helps stem cells repair tissue by directing their behavior.